Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Launched by INDIANA UNIVERSITY · Jun 2, 2023

Keywords

ClinConnect Summary

This clinical trial, called the Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer, is designed to help researchers better understand small cell lung cancer (SCLC) by collecting tumor tissue quickly after a patient's passing. The goal is to establish a program at the Indiana University Simon Comprehensive Cancer Center that allows for the collection of important tissue samples, which can provide valuable insights into the disease and improve future treatments.

To be eligible for this study, participants must be at least 18 years old and have a confirmed diagnosis of active small cell lung cancer. They also need to provide written consent to participate and allow researchers to access their health information. If you or someone you know is dealing with SCLC and meets these criteria, participating in this trial could help advance our understanding of the disease. Participants can expect to contribute to important research while ensuring their wishes and privacy are respected throughout the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. ≥ 18 years old at the time of informed consent
• • 2. Written informed consent and HIPAA authorization for release of personal health information.
• • 3. Active SCLC diagnosis.